… tend to be older with more advanced tumor stage at the time of diagnosis than those with
papillary cancer. About half who die from thyroid cancer suffer a pulmonary death, either …

… thyroid cancer is increasing faster than any other malignancy. Most papillary thyroid cancers
… Papillary thyroid cancer is a clinical challenge because it is difficult to prove benefit from the …

… for individuals diagnosed with low‐risk well‐differentiated thyroid cancer; better … of thyroid
cancer has improved thyroid cancer diagnosis and has enabled individualized therapeutic …

… on the treatment of anaplastic thyroid cancer (ATC) and thyroid lymphoma (TL). Results: Both
anaplastic carcinoma (ATC) and TL represent rare forms of thyroid cancer. ATC behaves in …

… primary tumors in patients treated for thyroid cancer. … primary tumors, but especially for
breast cancer, as data in the literature indicate an excessive risk in differentiated thyroid cancer (…

… ) given as treatment for thyroid cancer are difficult to assess since the number of thyroid
cancer patients treated at each centre is limited. The risk of second primary malignancies (SPMs) …

… age at diagnosis on second primary cancers without categorizing. In this … primary thyroid
cancer as an event. We have used SEER*Stat to obtain population rates of nonthyroid cancers …

… of primary cancer before thyroid cancer significantly enhanced the risk of second cancer has
… treatment modalities for thyroid cancer only, patients with a history of cancer may also have …

… therefore, identification of these rearrangements might have direct therapeutic relevance
to patients with thyroid cancer. Debate exists regarding the clinical implications of individual …

… of nonmedullary thyroid … thyroid cancer, and to discuss aspects on primary prevention of
the disease. In areas not associated with nuclear fallout, the annual incidence of thyroid cancer …